To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Tight junction protein 1 (TJP1)

Cancer

INDICATION: Multiple myeloma (MM)

Patient sample, cell culture and mouse studies suggest TJP1 could help treat MM. In MM patients, high

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE